Skip to main content
. 2021 Mar 12;12(4):610–616. doi: 10.1021/acsmedchemlett.1c00004

Table 2. Second Series of Quinazoline Derivativesa.

graphic file with name ml1c00004_0008.jpg

entry reactant R3 (intermediate) R4 product (yield %)
1 5a 4-methoxyphenyl (6a) morpholin-1-yl 7a (89.8)
2 5a 4-methoxyphenyl (6a) pyrrolidin-1-yl 7b (80.2)
3 5a 4-methoxyphenyl (6a) piperazin-1-yl 7c (79.6)
4 5a 4-methoxyphenyl (6a) diethylamino 7d (40.7)
5 5a 4-fluorophenyl (6b) morpholin-1-yl 7e (94.9)
6 5a 4-fluorophenyl (6b) pyrrolidin-1-yl 7f (96.6)
7 5a 4-fluorophenyl (6b) piperazin-1-yl 7g (90.8)
8 5a 4-fluorophenyl (6b) diethylamino 7h (34.7)
9 5a thiophen-2-yl (6c) morpholin-1-yl 7i (82.6)
10 5a thiophen-2-yl (6c) pyrrolidin-1-yl 7j (87.6)
11 5b 4-methoxyphenyl (6d) morpholin-1-yl 7k (90.1)
12 5b 4-methoxyphenyl (6d) pyrrolidin-1-yl 7l (91.8)
13 5b 4-methoxyphenyl (6d) piperazin-1-yl 7m (84.9)
14 5b 4-methoxyphenyl (6d) diethylamino 7n (54.4)
15 5b thiophen-2-yl (6e) morpholin-1-yl 7o (90.5)
a

Reagents and conditions: (a) corresponding boronic acid or ester, K2CO3, PdCl2(PPh3)2, toluene/dioxane/water (10:5:8, v/v/v), 90 °C, overnight; (b) corresponding secondary amine, KI, K2CO3, N,N-diisopropylethylamine, dimethylformamide, 110 °C, overnight.